Last reviewed · How we verify
NCT06383858
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center
trial testing Screening method in Preeclampsia in 50,000 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | The Third Affiliated Hospital of Guangzhou Medical University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50,000 |
| Start date | 1 August 2023 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- Screening method
- Screening method
Conditions studied
- Preeclampsia — all drugs for Preeclampsia →
- Maternal Deaths — all drugs for Maternal Deaths →
Sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Who can join
18 and older, female only, with Preeclampsia or Maternal Deaths. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Preeclampsia is the main cause of illness and death in pregnant women and fetuses. Currently, there is no effective treatment for preeclampsia in clinical practice, and the fundamental treatment is still termination of pregnancy and placental delivery. Therefore, early prediction of preeclampsia and targeted strengthening of high-risk pregnant women supervision, early intervention and diagnosis and treatment can greatly reduce the serious obstetric complications and perinatal maternal and fetal deaths caused by preeclampsia, which has significant social and clinical significance.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
sFlt-1/PlGF Ratio Predicts Short-Term Maternal-Fetal Outcomes in Chinese Hypertensive Pregnancies: A Prospective Cohort Study.
Tang J, Xiao D, Yang S, Fang L, et al · · 2026 · cited 1× · PMID 40948128 · DOI 10.1161/hypertensionaha.125.25022
Verify or expand the search:
- PubMed search for NCT06383858
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preeclampsia
Currently open trials in the same condition.
- NCT06953115 — Vagal Stimulation Therapy and Preeclampsia · NA · recruiting
- NCT06333652 — Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders · Phase 2 · recruiting
- NCT07282171 — A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Parti · Phase 1 · recruiting
- NCT07345845 — MR and Inflammation After Preeclampsia · EARLY_PHASE1 · active not recruiting
- NCT07041281 — Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories · Phase 2 · recruiting
Other The Third Affiliated Hospital of Guangzhou Medical University trials
Trials by the same sponsor.
- NCT07533929 — Incidence and Predictors of Elevated ALT in Postpartum CHB Mothers · not yet recruiting
- NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
- NCT06711601 — Ultrasound Evaluation of Two Anatomic Landmarks in Spinal Anesthesia for Cesarean Section: the Posterior Superior Iliac · recruiting
- NCT06420427 — Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery · recruiting
- NCT06180590 — The Efficacy of Vosevi in Treating DAA-experienced Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06383858 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Affiliated Hospital of Guangzhou Medical University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06383858.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing